A survey in the American Journal of Obstetrics & Gynecology revealed that patients with chronic gynecologic pain were twice as likely to use social media to understand or manage their condition than those without pain, at 37.8% vs 19.7% respectively.
Check out what events and programs the American Urogynecologic Society is hosting over the next several months.
What's coming to Contemporary OB/GYN® this week.
A cohort study in JAMA Pediatrics indicates that policies that increase access to immediate postpartum long-acting reversible contraception (LARC) improve birth outcomes.
Nearly $19 billion in total aid has been distributed to providers since November 2021.
Polycystic ovary syndrome (PCOS) and type 2 diabetes have some markers that suggest a connection, with PCOS patients exhibiting certain symptoms at greater risk of developing type 2 diabetes later. A systematic review examines the prevalence of the 2 conditions occurring in adolescent girls.
In this episode of Pap Talk, Gloria Bachmann, MD, MSc, breaks down what it means to be a health care provider for incarcerated individuals, and explores the specific challenges women and their providers face during and after incarceration. Joined by sexual health expert Michael Krychman, MD, Bachmann also discusses trauma-informed care and how providers can get informed.
Rachel Rubin, MD, an assistant clinical professor in urology at Georgetown University and a urologic surgeon, discusses how hypoactive sexual desire disorder in women was defined and treated historically.
Thomasina Morris, RPh, MHA, BCOP, pharmacist at Moffitt Cancer Center, discusses the mechanism of action of rucaparib in recurrent and second line ovarian cancer, fallopian tube cancer, and peritoneal cancer.
Check out the week’s top stories.
Don’t dread a call from OCR investigators. They are here to help physicians and other providers avoid astronomical monetary penalties.
Data shows some encouraging trends, but filling positions proving difficult with costs increasing.
Almost a quarter are thinking about leaving health care after 2 years of a pandemic.
Novel therapies could potentially expand the population of patients with ERBB2-positive metastatic breast cancer who experience long-lasting disease response, according to a review in JAMA Oncology.
Many will be forced to forgo care or return to the workforce to pay health care bills.
After 10 years women’s median earnings are 9% less than men’s.
Contemporary OB/GYN® Associate Editor Lindsey Carr sat down with Jessica Shim, MD, an attending at in the Division of Gynecology, Department of Surgery, Boston Children’s Hospital; Harvard Medical School Boston, Massachusetts, to discuss Myfembree (relugolix, estradiol, and norethindrone acetate tablets; Myovant Sciences, Pfizer) and its possible approval in May 2022.
About 1 in 5 girls with pediatric type 2 diabetes (T2D) also has polycystic ovary syndrome (PCOS), according to a systematic review and meta-analysis in JAMA Network Open.
A quality improvement study in JAMA Network Open has found that a significantly lower percentage of patients with breast cancer presented with stage I disease before the COVID-19 pandemic, in 2019, compared to after the start of the pandemic, in 2020.
COVID-19 updates and news to know as of February 21, 2022.
The American Urogynecologic Society (AUGS) published an executive summary on postoperative opioid prescribing after female pelvic medicine and reconstructive surgery.
Twenty-nine HRSA-funded health centers to receive a boost in technology to improve outcomes.
Stopping some doctors from sharing unsound medical advice has proved challenging. Even defining misinformation has been difficult. And during the pandemic, resistance from some state legislatures is complicating the effort.
Dr. Lorna Breen Health Care Provider Protection Act aims to help physicians receive mental health assistance without jeopardizing their licenses.
It was a busy week for the Contemporary OB/GYN® team.
Cancer misinformation may be more prevalent among residents in rural vs urban areas, study finds.
Risk factors for the dual burden of severe maternal morbidity and preterm birth differ significantly by insurance type across sociodemographic and perinatal considerations in the state of California, according to a study in the Maternal and Children Health Journal.
Patients with acute vulvovaginal candidiasis (VVC) greatly benefited from oral ibrexafungerp (Brexafemme, Scynexis), according to results of a global phase 3 randomized, double-blind, placebo-controlled superiority study published in the international journal of obstetrics and gynecology, BJOG.
Many new therapies have been developed over the past decade to treat disorders that are often present at birth and early treatment can lead to better outcomes. However, the screenings for newborns have been slow to adapt.
Patients with endometriosis are nearly four times as likely to develop rheumatoid arthritis (RA) than those without endometriosis, according to a study in the Journal of Women’s Health.
